Pilot randomised controlled trial of meropenem versus piperacillin-tazobactam for the definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp, ... (2015)

Experts

NHMRC Emerging Leadership Fellow: Frazer Institute; Faculty of Health, Medicine and Behavioural Sciences

Associate Professor, Infectious Diseases: Frazer Institute; Faculty of Health, Medicine and Behavioural Sciences

Patrick Harris

Affiliate of UQ Centre for Clinical Research: UQ Centre for Clinical Research; Faculty of Health, Medicine and Behavioural Sciences

Emeritus/Emerita/Emeritx Professor: Frazer Institute; Faculty of Health, Medicine and Behavioural Sciences

Jeffrey Lipman